Brett Marinelli

Memorial Sloan Kettering Cancer Center

Papers

4

Total Citations

74

H-Index

3

About

Brett Marinelli is a rising leader in interventional oncology, whose research focuses on the cutting-edge integration of robotic systems into percutaneous liver and lung interventions. His major contributions include pioneering systematic reviews that critically evaluate the clinical viability and outcomes of robotic-guided biopsies and tumor ablations, providing a foundational evidence base for this rapidly evolving field. His 2023 systematic review on robotic liver interventions has garnered 32 citations, while his 2024 work on robotic lung biopsies has accumulated 16 citations, underscoring the timely relevance of his analyses. Notably, his 2024 comparative study of a patient-mounted needle-driving robotic system against single-rotation CT fluoroscopy for lung biopsies (24 citations) directly addresses a critical clinical question: whether robotic assistance can improve procedural accuracy and safety. Most recently, Marinelli has extended his work to robotic placement of hepatic artery infusion pumps for advanced liver malignancies, comparing outcomes against traditional open surgery in a 2025 study. Through his methodical evaluations and clinical comparisons, Marinelli is shaping the future of minimally invasive, image-guided interventions, making him a key voice for students and researchers interested in the convergence of robotics and interventional radiology.

Research Focus

Key Achievements

3
H-Index
4
Papers
74
Total Citations
19
Avg Citations/Paper
🏆 Most Cited Paper
Percutaneous liver interventions with robotic systems: a systematic review of available clinical solutions
32 citations · 2023
📈 Most Prolific Year: 2024 (2 Papers)
🤝 Key Collaborators: 24
🏛 Institutions: Memorial Sloan Kettering Cancer Center

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago